This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42289226
rdf:type
wikibase:Item
schema:description
1993年论文 tieteellinen artikkeli videnskabelig artikel 1993年论文 scienca artikolo 1993年論文 bilimsel makale სამეცნიერო სტატია articol științific 1993年论文 vedecký článok 1993年論文 artículu científicu espublizáu en 1993 1993年の論文 tudományos cikk artigo científico wetenschappelijk artikel מאמר מדעי научная статья artikel ilmiah artigo científico บทความทางวิทยาศาสตร์ bài báo khoa học 1993년 논문 1993年論文 article scientifique vědecký článek wissenschaftlicher Artikel artykuł naukowy artikull shkencor teaduslik artikkel articolo scientifico naučni članak scientific article published on January 1993 научни чланак мақолаи илмӣ artigo científico article científic 1993年论文 scientific article published on January 1993 article scientific наукова стаття, опублікована в січні 1993 vitenskapelig artikkel vetenskaplig artikel 1993年論文 1993年论文 1993年论文 1993年論文 artículo científico publicado en 1993 artikulong pang-agham 1993 nî lūn-bûn επιστημονικό άρθρο مقالة علمية نشرت في يناير 1993 научна статия scientific article published on January 1993 vitskapeleg artikkel জানুয়ারি ১৯৯৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак
p:P577
wds:Q42289226-EEEB48C8-936E-4530-A783-583CB5D3CCB7
wdt:P577
1993-01-01T00:00:00Z
p:P407
wds:Q42289226-8CD6CD3C-5BA9-4383-B197-88317365AF5D
wdt:P407
wd:Q1860
p:P2860
wds:Q42289226-6ADDFCA1-9EB3-42C4-92DA-4653CE17DC0A wds:Q42289226-6AFD4452-E3C0-42A6-8BF1-E0D99CD72CCF wds:Q42289226-6DDE9A73-207B-48A2-AF8D-CEDBE84BF5BF wds:Q42289226-3827C0B9-09DF-4418-8762-BE09EC159933 wds:Q42289226-5034BEB7-7CC1-4A89-8D6F-590DCD85296C wds:Q42289226-2F1C6764-D311-45FA-B1A3-E889FD155892 wds:Q42289226-FF1CF040-C858-4D4C-9A62-95E8C3D4CD67 wds:Q42289226-ED1EF72B-774D-46B7-ACA8-ED66E7F7FF6C wds:Q42289226-E0690DCE-CDE4-4DF1-BDBF-488A77D2F7E7 wds:Q42289226-E5D4656A-73D1-41FE-9FB4-72F63806D319 wds:Q42289226-B2E9BA61-3418-419A-871E-01EE954D5382 wds:Q42289226-9D77C43D-E03C-4CA2-84BA-A414EA4F5BB3 wds:Q42289226-6E55F3ED-50D5-4504-A7A4-F65BBFA68FD6 wds:Q42289226-7C0B8C89-C383-428D-9EE5-C506BD67A6EB
wdt:P2860
wd:Q45853622 wd:Q45843620 wd:Q45062529 wd:Q45853602 wd:Q43517743 wd:Q69483859 wd:Q69965650 wd:Q34506987 wd:Q44134576 wd:Q42216107 wd:Q68360980 wd:Q29620785 wd:Q34558599 wd:Q68942769
p:P2093
wds:Q42289226-61030629-3E29-44AF-AE14-FC2C9957D06B wds:Q42289226-41FA6BF2-704A-4C7D-B27F-1D2E4DB72CF2 wds:Q42289226-617F4D9B-0373-4A77-944A-3663DFC12D4F wds:Q42289226-244EDFD8-60F9-45CF-ABD5-6F025BCB9236 wds:Q42289226-A7DB4B51-BD01-4ABE-AAFC-C78CC8BDAF04 wds:Q42289226-B5D40FF3-FFD8-40B3-977E-C0BD04F3575E wds:Q42289226-BE850554-8437-47C0-9A4E-7670E2813F5E wds:Q42289226-9A53C486-4208-460C-8170-83FCB52F4CFE wds:Q42289226-8CF89FE4-C105-448C-AD33-BF962156A4D2
wdt:P2093
McKinney R Jr Boucher FD Crain MJ Modlin JF Ruff A Wilfert C Mirochnick M Elkins MM Weller S
rdfs:label
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
skos:prefLabel
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
schema:name
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
p:P50
wds:Q42289226-7EFC0A9B-620A-44B7-A687-028EDC3D8589
wdt:P50
wd:Q41485813
p:P1476
wds:Q42289226-073E910B-E763-44F5-8D99-6F2A5C866E3D
wdt:P1476
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
p:P304
wds:Q42289226-0AB5A7C3-015E-4703-948D-1042B6F5CB25
wdt:P304
137-144
p:P31
wds:Q42289226-F08F87F2-E18E-4688-9646-5E0264CDA2D5
wdt:P31
wd:Q13442814
p:P921
wds:Q42289226-F4721A5B-2427-437C-8BCD-17726D89FC9B
wdt:P921
wd:Q198504
p:P698
wds:Q42289226-A71A7FD6-D693-46FB-A524-3FD27471C0E6
wdtn:P698
n7:8419601
wdt:P698
8419601
p:P1433
wds:Q42289226-FFD170F7-9FCA-4860-BA9B-12F551F6C14C
wdt:P1433
wd:Q7743611
p:P433
wds:Q42289226-EB07DF88-F952-44EC-AE9F-32FBFDE1DD76
p:P478
wds:Q42289226-745F29A5-8570-4418-96D8-B146B7CD53C7
wdt:P433
1
wdt:P478
122
p:P356
wds:Q42289226-A537AC2F-1DE8-4D21-9780-9134BA37A68E
wdtn:P356
n9:S0022-3476(05)83507-3
wdt:P356
10.1016/S0022-3476(05)83507-3